Even though there are macro challenges still weighing on Align Technology (NASDAQ:ALGN), Brigantine sees key operating metrics heading in the right direction, and continue to like the company.
Brigantine says, "We are pleased by the direction of key operating metrics including case starts, utilization and pricing, particularly given the macro challenges. With expanding product capabilities and emerging market opportunities, we remain buyers and keep a $23 price target."
Brigantine Advisors maintains a "Buy" rating on Align Technology (ALGN), which closed Thursday at $20.90, up $0.39, or 1.91 percent.
No comments:
Post a Comment